These findings position 4n as a promising selective ADRA2A antagonist, offering a valuable tool for studying adrenoceptor subtypes in inflammatory disorders and sepsis and a novel preclinical candidate for ADRA2A-mediated pathologies. The gene discussed is ADRA2A; the disease is Sepsis.